

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.95176009 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.92595855 |
| 3 | response to peptidoglycan (GO:0032494) | 4.68043756 |
| 4 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.63347015 |
| 5 | microglial cell activation (GO:0001774) | 4.46646427 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.29750817 |
| 7 | fucose catabolic process (GO:0019317) | 4.29555638 |
| 8 | L-fucose metabolic process (GO:0042354) | 4.29555638 |
| 9 | L-fucose catabolic process (GO:0042355) | 4.29555638 |
| 10 | superoxide anion generation (GO:0042554) | 4.16771757 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14802014 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.01025706 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.01025706 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84470079 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.84470079 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84470079 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84470079 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84470079 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.84470079 |
| 20 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.83626894 |
| 21 | negative regulation of mast cell activation (GO:0033004) | 3.73212907 |
| 22 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.68096005 |
| 23 | DNA deamination (GO:0045006) | 3.66290821 |
| 24 | negative regulation of interleukin-1 production (GO:0032692) | 3.64535034 |
| 25 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.63583564 |
| 26 | dendritic cell chemotaxis (GO:0002407) | 3.60622750 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51953586 |
| 28 | neutrophil activation (GO:0042119) | 3.49658981 |
| 29 | facial nerve structural organization (GO:0021612) | 3.48791591 |
| 30 | dendritic cell migration (GO:0036336) | 3.44451313 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 3.38164264 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 3.38164264 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.38164264 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37465436 |
| 35 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.36497575 |
| 36 | activated T cell proliferation (GO:0050798) | 3.36176675 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.35480476 |
| 38 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.33773072 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.31429809 |
| 40 | oligosaccharide catabolic process (GO:0009313) | 3.29685137 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 3.29643431 |
| 42 | indolalkylamine metabolic process (GO:0006586) | 3.28527048 |
| 43 | lipoxygenase pathway (GO:0019372) | 3.27987892 |
| 44 | detection of other organism (GO:0098543) | 3.26874712 |
| 45 | omega-hydroxylase P450 pathway (GO:0097267) | 3.24879764 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21021978 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19845976 |
| 48 | regulation of mast cell activation (GO:0033003) | 3.19816535 |
| 49 | macrophage activation (GO:0042116) | 3.19736009 |
| 50 | granulocyte activation (GO:0036230) | 3.18681955 |
| 51 | respiratory burst (GO:0045730) | 3.18612223 |
| 52 | response to host immune response (GO:0052572) | 3.14171457 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14171457 |
| 54 | regulation of antigen processing and presentation (GO:0002577) | 3.13094055 |
| 55 | kynurenine metabolic process (GO:0070189) | 3.12625773 |
| 56 | cytidine deamination (GO:0009972) | 3.11741055 |
| 57 | cytidine metabolic process (GO:0046087) | 3.11741055 |
| 58 | cytidine catabolic process (GO:0006216) | 3.11741055 |
| 59 | mature B cell differentiation (GO:0002335) | 3.10923892 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07944550 |
| 61 | positive regulation of T cell migration (GO:2000406) | 3.07938793 |
| 62 | phagocytosis, engulfment (GO:0006911) | 3.07378454 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 3.06985830 |
| 64 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04080363 |
| 65 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.00893161 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00316346 |
| 67 | response to interleukin-15 (GO:0070672) | 3.00222962 |
| 68 | adaptation of signaling pathway (GO:0023058) | 2.99765976 |
| 69 | negative regulation of granulocyte differentiation (GO:0030853) | 2.98608332 |
| 70 | regulation of memory T cell differentiation (GO:0043380) | 2.98366199 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.97103755 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 2.96232426 |
| 73 | positive regulation of defense response to virus by host (GO:0002230) | 2.95994600 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94431746 |
| 75 | tryptophan metabolic process (GO:0006568) | 2.92491992 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92479385 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91029079 |
| 78 | regulation of activation of Janus kinase activity (GO:0010533) | 2.90282198 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 2.88493634 |
| 80 | amino sugar catabolic process (GO:0046348) | 2.87361826 |
| 81 | positive regulation of lymphocyte migration (GO:2000403) | 2.87232955 |
| 82 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.86449897 |
| 83 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.85756534 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.85348704 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.84192583 |
| 86 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.83882431 |
| 87 | negative regulation of telomere maintenance (GO:0032205) | 2.83871808 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 2.83638836 |
| 89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83638836 |
| 90 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82821309 |
| 91 | cellular extravasation (GO:0045123) | 2.81884297 |
| 92 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.81326019 |
| 93 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77625024 |
| 94 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76756043 |
| 95 | regulation of monocyte chemotaxis (GO:0090025) | 2.73853725 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 2.71246466 |
| 97 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70007602 |
| 98 | NAD biosynthetic process (GO:0009435) | 2.69904010 |
| 99 | mast cell activation (GO:0045576) | 2.69871944 |
| 100 | cellular response to exogenous dsRNA (GO:0071360) | 2.69234611 |
| 101 | myeloid dendritic cell activation (GO:0001773) | 2.68643138 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.68531071 |
| 103 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.68254955 |
| 104 | cranial nerve structural organization (GO:0021604) | 2.67022791 |
| 105 | positive regulation of chemokine secretion (GO:0090197) | 2.66870412 |
| 106 | purinergic receptor signaling pathway (GO:0035587) | 2.66686553 |
| 107 | regulation of T cell migration (GO:2000404) | 2.66421617 |
| 108 | rRNA catabolic process (GO:0016075) | 2.66006738 |
| 109 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.64532421 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.64355690 |
| 111 | interferon-gamma production (GO:0032609) | 2.64176051 |
| 112 | neural tube formation (GO:0001841) | 2.64055480 |
| 113 | response to host (GO:0075136) | 2.63627299 |
| 114 | response to host defenses (GO:0052200) | 2.63627299 |
| 115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63627299 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63202395 |
| 117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.62938434 |
| 118 | definitive hemopoiesis (GO:0060216) | 2.61952638 |
| 119 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.61317671 |
| 120 | membrane invagination (GO:0010324) | 2.60517279 |
| 121 | myeloid leukocyte activation (GO:0002274) | 2.60137398 |
| 122 | response to interferon-beta (GO:0035456) | 2.59949357 |
| 123 | sulfation (GO:0051923) | 2.57750553 |
| 124 | tolerance induction (GO:0002507) | 2.56760452 |
| 125 | response to pheromone (GO:0019236) | 2.56360791 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.55939056 |
| 127 | detection of light stimulus involved in visual perception (GO:0050908) | 2.55400199 |
| 128 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.55400199 |
| 129 | positive regulation of interferon-alpha production (GO:0032727) | 2.55316580 |
| 130 | ceramide catabolic process (GO:0046514) | 2.55052670 |
| 131 | detection of bacterium (GO:0016045) | 2.53426595 |
| 132 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.52684858 |
| 133 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.52527841 |
| 134 | detection of molecule of bacterial origin (GO:0032490) | 2.52375351 |
| 135 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51803455 |
| 136 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50967576 |
| 137 | leukocyte aggregation (GO:0070486) | 2.50632295 |
| 138 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.50576350 |
| 139 | glycolipid catabolic process (GO:0019377) | 2.50284591 |
| 140 | positive regulation of T cell chemotaxis (GO:0010820) | 2.49913197 |
| 141 | regulation of T cell chemotaxis (GO:0010819) | 2.49913197 |
| 142 | defense response to protozoan (GO:0042832) | 2.49061353 |
| 143 | pinocytosis (GO:0006907) | 2.48159379 |
| 144 | response to folic acid (GO:0051593) | 2.47795866 |
| 145 | lymphoid progenitor cell differentiation (GO:0002320) | 2.46543499 |
| 146 | amine catabolic process (GO:0009310) | 2.45917781 |
| 147 | cellular biogenic amine catabolic process (GO:0042402) | 2.45917781 |
| 148 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.45677258 |
| 149 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.45208772 |
| 150 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.45208772 |
| 151 | daunorubicin metabolic process (GO:0044597) | 2.45017189 |
| 152 | polyketide metabolic process (GO:0030638) | 2.45017189 |
| 153 | doxorubicin metabolic process (GO:0044598) | 2.45017189 |
| 154 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.44736856 |
| 155 | leukocyte degranulation (GO:0043299) | 2.43992659 |
| 156 | indole-containing compound metabolic process (GO:0042430) | 2.41790863 |
| 157 | detection of external biotic stimulus (GO:0098581) | 2.41734981 |
| 158 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.39562899 |
| 159 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.39016047 |
| 160 | killing of cells of other organism (GO:0031640) | 2.38550109 |
| 161 | disruption of cells of other organism (GO:0044364) | 2.38550109 |
| 162 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.37485944 |
| 163 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.37212004 |
| 164 | regulation of regulatory T cell differentiation (GO:0045589) | 2.33999752 |
| 165 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.33629101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.07547774 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81767753 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.61260139 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24534155 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88799310 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88618447 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77421042 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66095437 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.64371937 |
| 10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.51590951 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.48071976 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.47377264 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37239520 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.37020737 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22970347 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16495423 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08316359 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05379395 |
| 19 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.04663617 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03312055 |
| 21 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.99883370 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97077629 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96676766 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95631534 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86175329 |
| 26 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.81809334 |
| 27 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.78811563 |
| 28 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.77574246 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77466221 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74484199 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.72517403 |
| 32 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.69698778 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67897736 |
| 34 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.67759991 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67416185 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66661922 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66417370 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64341647 |
| 39 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.62650301 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60555005 |
| 41 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.60250521 |
| 42 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.60070447 |
| 43 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.59110366 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58591858 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58006445 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.57596193 |
| 47 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.57381689 |
| 48 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.55891090 |
| 49 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.54910318 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52012912 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50281075 |
| 52 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.49631049 |
| 53 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.48999091 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48513589 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47752221 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46636680 |
| 57 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.45305380 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.44975266 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44955425 |
| 60 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44355492 |
| 61 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.41988542 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39990109 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39987666 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39817030 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39583357 |
| 66 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.39288487 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38526697 |
| 68 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38240020 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35665098 |
| 70 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.34702760 |
| 71 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34170530 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33312373 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31837992 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31390553 |
| 75 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.30872025 |
| 76 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.30418644 |
| 77 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.30173394 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.28090000 |
| 79 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.27527049 |
| 80 | ERA_21632823_ChIP-Seq_H3396_Human | 1.26588939 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.26258969 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.26258969 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26096726 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25828724 |
| 85 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25681136 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24979181 |
| 87 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.24571932 |
| 88 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24132342 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23935255 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22020821 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21244363 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20512127 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19574537 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19397155 |
| 95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18810746 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18169799 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18169799 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.17943824 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16683658 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15887600 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15617783 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15381773 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15347150 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14690751 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14297505 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13862803 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13593003 |
| 108 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13212596 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13065082 |
| 110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12078171 |
| 111 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11872820 |
| 112 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11858693 |
| 113 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11722239 |
| 114 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11614101 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11590758 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10529220 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10195975 |
| 118 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10015720 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09754283 |
| 120 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.09615330 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09515205 |
| 122 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08829904 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08639532 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08496543 |
| 125 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07775834 |
| 126 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07359095 |
| 127 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07075461 |
| 128 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07075461 |
| 129 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06773698 |
| 130 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06268495 |
| 131 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05666373 |
| 132 | MYB_26560356_Chip-Seq_TH2_Human | 1.05355245 |
| 133 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05275920 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04974927 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04421254 |
| 136 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04265698 |
| 137 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02744212 |
| 138 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02164891 |
| 139 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01739360 |
| 140 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01388390 |
| 141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00902487 |
| 142 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00282427 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00165888 |
| 144 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00134146 |
| 145 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99931529 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98965947 |
| 147 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.98792528 |
| 148 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98114114 |
| 149 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.96305104 |
| 150 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.95883111 |
| 151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95869482 |
| 152 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95207916 |
| 153 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94404009 |
| 154 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.94364077 |
| 155 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94214286 |
| 156 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94214286 |
| 157 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94028067 |
| 158 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93592916 |
| 159 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.92762413 |
| 160 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.91918815 |
| 161 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91114607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.07937580 |
| 2 | MP0003136_yellow_coat_color | 3.68648116 |
| 3 | MP0003724_increased_susceptibility_to | 3.35791617 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.16983588 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.99727260 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.92590560 |
| 7 | MP0001188_hyperpigmentation | 2.92359948 |
| 8 | MP0005671_abnormal_response_to | 2.83465734 |
| 9 | MP0003195_calcinosis | 2.77403612 |
| 10 | MP0003436_decreased_susceptibility_to | 2.62392868 |
| 11 | MP0002419_abnormal_innate_immunity | 2.62237707 |
| 12 | MP0009785_altered_susceptibility_to | 2.62195897 |
| 13 | MP0005409_darkened_coat_color | 2.61919908 |
| 14 | MP0000015_abnormal_ear_pigmentation | 2.57558081 |
| 15 | MP0004381_abnormal_hair_follicle | 2.39941646 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.38356478 |
| 17 | MP0003646_muscle_fatigue | 2.36551114 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 2.28610786 |
| 19 | MP0005174_abnormal_tail_pigmentation | 2.22531438 |
| 20 | MP0005025_abnormal_response_to | 2.14374302 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.12226136 |
| 22 | MP0001800_abnormal_humoral_immune | 2.04291557 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.99796984 |
| 24 | MP0006082_CNS_inflammation | 1.96194702 |
| 25 | MP0002723_abnormal_immune_serum | 1.92084283 |
| 26 | MP0001790_abnormal_immune_system | 1.86979181 |
| 27 | MP0005387_immune_system_phenotype | 1.86979181 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.86625818 |
| 29 | MP0005171_absent_coat_pigmentation | 1.82603136 |
| 30 | MP0001819_abnormal_immune_cell | 1.80907286 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.80417776 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.80005051 |
| 33 | MP0002009_preneoplasia | 1.77286350 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.73145735 |
| 35 | MP0000427_abnormal_hair_cycle | 1.69070836 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.68165210 |
| 37 | MP0008872_abnormal_physiological_respon | 1.63422525 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.61125855 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.55495806 |
| 40 | MP0004043_abnormal_pH_regulation | 1.52698487 |
| 41 | MP0008260_abnormal_autophagy | 1.52496801 |
| 42 | MP0002095_abnormal_skin_pigmentation | 1.52134323 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.48626333 |
| 44 | MP0003787_abnormal_imprinting | 1.46852033 |
| 45 | MP0000372_irregular_coat_pigmentation | 1.46648943 |
| 46 | MP0002132_abnormal_respiratory_system | 1.46567182 |
| 47 | MP0002405_respiratory_system_inflammati | 1.46249997 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.44865215 |
| 49 | MP0000685_abnormal_immune_system | 1.44757872 |
| 50 | MP0004130_abnormal_muscle_cell | 1.44468484 |
| 51 | MP0009764_decreased_sensitivity_to | 1.43671768 |
| 52 | MP0000566_synostosis | 1.43621088 |
| 53 | MP0003011_delayed_dark_adaptation | 1.41373713 |
| 54 | MP0002102_abnormal_ear_morphology | 1.41066850 |
| 55 | MP0002928_abnormal_bile_duct | 1.39481210 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.39086849 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.38511173 |
| 58 | MP0003878_abnormal_ear_physiology | 1.34573477 |
| 59 | MP0005377_hearing/vestibular/ear_phenot | 1.34573477 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.34060720 |
| 61 | MP0005310_abnormal_salivary_gland | 1.33328730 |
| 62 | MP0000343_altered_response_to | 1.33104510 |
| 63 | MP0004510_myositis | 1.32060095 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.32001946 |
| 65 | MP0009697_abnormal_copulation | 1.27126984 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.25500041 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25092782 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.23670717 |
| 69 | MP0001853_heart_inflammation | 1.23394024 |
| 70 | MP0009745_abnormal_behavioral_response | 1.22026314 |
| 71 | MP0009379_abnormal_foot_pigmentation | 1.20548475 |
| 72 | MP0000716_abnormal_immune_system | 1.20136782 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.19351179 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.18753945 |
| 75 | MP0002933_joint_inflammation | 1.17324409 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.14322680 |
| 77 | MP0003828_pulmonary_edema | 1.13362622 |
| 78 | MP0002638_abnormal_pupillary_reflex | 1.12929675 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.12219627 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.12088964 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.10944106 |
| 82 | MP0008004_abnormal_stomach_pH | 1.10469256 |
| 83 | MP0002398_abnormal_bone_marrow | 1.07851110 |
| 84 | MP0005083_abnormal_biliary_tract | 1.06966791 |
| 85 | MP0009046_muscle_twitch | 1.06625640 |
| 86 | MP0003866_abnormal_defecation | 1.06595518 |
| 87 | MP0008469_abnormal_protein_level | 1.06313450 |
| 88 | MP0001485_abnormal_pinna_reflex | 1.05435719 |
| 89 | MP0002693_abnormal_pancreas_physiology | 1.05402653 |
| 90 | MP0002736_abnormal_nociception_after | 1.05348573 |
| 91 | MP0003690_abnormal_glial_cell | 1.04843830 |
| 92 | MP0003045_fibrosis | 1.03756139 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 1.02618157 |
| 94 | MP0000689_abnormal_spleen_morphology | 1.01729501 |
| 95 | MP0003303_peritoneal_inflammation | 1.01560619 |
| 96 | MP0004885_abnormal_endolymph | 0.99117189 |
| 97 | MP0001873_stomach_inflammation | 0.99026795 |
| 98 | MP0005253_abnormal_eye_physiology | 0.97778055 |
| 99 | MP0002429_abnormal_blood_cell | 0.92677845 |
| 100 | MP0003252_abnormal_bile_duct | 0.92505349 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.91477447 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.91449367 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.90725167 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.90372642 |
| 105 | MP0002006_tumorigenesis | 0.90185205 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.89380159 |
| 107 | MP0005646_abnormal_pituitary_gland | 0.89272113 |
| 108 | MP0004147_increased_porphyrin_level | 0.88803807 |
| 109 | MP0000470_abnormal_stomach_morphology | 0.88783356 |
| 110 | MP0002733_abnormal_thermal_nociception | 0.88719471 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.88410006 |
| 112 | MP0000490_abnormal_crypts_of | 0.87678939 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.87384826 |
| 114 | MP0001970_abnormal_pain_threshold | 0.86675923 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.86643861 |
| 116 | MP0005410_abnormal_fertilization | 0.86404662 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.85461092 |
| 118 | MP0002722_abnormal_immune_system | 0.85406323 |
| 119 | MP0000858_altered_metastatic_potential | 0.85357986 |
| 120 | MP0002064_seizures | 0.84020405 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.83977614 |
| 122 | MP0004742_abnormal_vestibular_system | 0.83584505 |
| 123 | MP0001486_abnormal_startle_reflex | 0.83117419 |
| 124 | MP0004883_abnormal_blood_vessel | 0.82197809 |
| 125 | MP0005389_reproductive_system_phenotype | 0.80411980 |
| 126 | MP0003075_altered_response_to | 0.79846552 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.79410550 |
| 128 | MP0002272_abnormal_nervous_system | 0.78960935 |
| 129 | MP0003279_aneurysm | 0.77658354 |
| 130 | MP0005390_skeleton_phenotype | 0.76828631 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.76281919 |
| 132 | MP0000767_abnormal_smooth_muscle | 0.75983115 |
| 133 | MP0005164_abnormal_response_to | 0.75911475 |
| 134 | MP0003941_abnormal_skin_development | 0.75748190 |
| 135 | MP0002876_abnormal_thyroid_physiology | 0.75213832 |
| 136 | MP0001186_pigmentation_phenotype | 0.73552733 |
| 137 | MP0001663_abnormal_digestive_system | 0.73340246 |
| 138 | MP0001851_eye_inflammation | 0.72898275 |
| 139 | MP0001919_abnormal_reproductive_system | 0.72783451 |
| 140 | MP0008058_abnormal_DNA_repair | 0.72479060 |
| 141 | MP0000920_abnormal_myelination | 0.69675044 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.68890907 |
| 143 | MP0000026_abnormal_inner_ear | 0.64851467 |
| 144 | MP0004142_abnormal_muscle_tone | 0.62620781 |
| 145 | MP0003448_altered_tumor_morphology | 0.61904183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.30421587 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.52643118 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.01888743 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.01097244 |
| 5 | Pancreatic cysts (HP:0001737) | 3.88686078 |
| 6 | Congenital stationary night blindness (HP:0007642) | 3.86431978 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.75144102 |
| 8 | Chromsome breakage (HP:0040012) | 3.57348933 |
| 9 | Glomerulonephritis (HP:0000099) | 3.50980244 |
| 10 | Abnormality of secondary sexual hair (HP:0009888) | 3.45643108 |
| 11 | Abnormality of the axillary hair (HP:0100134) | 3.45643108 |
| 12 | Prostate neoplasm (HP:0100787) | 3.39008606 |
| 13 | Obstructive lung disease (HP:0006536) | 3.36196450 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.36196450 |
| 15 | Optic neuritis (HP:0100653) | 3.34778312 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.34778312 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.31378041 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.31378041 |
| 19 | Recurrent skin infections (HP:0001581) | 3.25202367 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.22569350 |
| 21 | True hermaphroditism (HP:0010459) | 3.13340070 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.11643391 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.11643391 |
| 24 | Myositis (HP:0100614) | 3.05888320 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.03535307 |
| 26 | Type II lissencephaly (HP:0007260) | 3.02703941 |
| 27 | Attenuation of retinal blood vessels (HP:0007843) | 3.01285064 |
| 28 | Orchitis (HP:0100796) | 3.00052872 |
| 29 | Meningitis (HP:0001287) | 2.95790345 |
| 30 | Nephronophthisis (HP:0000090) | 2.91406890 |
| 31 | Clubbing of toes (HP:0100760) | 2.87509060 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.86211381 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.85485508 |
| 34 | Prolonged bleeding time (HP:0003010) | 2.84779916 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.82125473 |
| 36 | Stomatitis (HP:0010280) | 2.81976575 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.77562575 |
| 38 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.76887040 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.74381954 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74168989 |
| 41 | Hyperventilation (HP:0002883) | 2.73531381 |
| 42 | Stomach cancer (HP:0012126) | 2.71289805 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 2.69324280 |
| 44 | Dry hair (HP:0011359) | 2.68187927 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.66482994 |
| 46 | Progressive inability to walk (HP:0002505) | 2.65438236 |
| 47 | Patchy hypopigmentation of hair (HP:0011365) | 2.61820826 |
| 48 | Recurrent fungal infections (HP:0002841) | 2.61423429 |
| 49 | Hypochromic anemia (HP:0001931) | 2.58608814 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.58494231 |
| 51 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.56380594 |
| 52 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54890801 |
| 53 | Polydipsia (HP:0001959) | 2.53369351 |
| 54 | Abnormal drinking behavior (HP:0030082) | 2.53369351 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.53216330 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 2.53095368 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53047666 |
| 58 | Decreased circulating renin level (HP:0003351) | 2.51985466 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.51640830 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.49211614 |
| 61 | Hyperalaninemia (HP:0003348) | 2.49211614 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49211614 |
| 63 | Inability to walk (HP:0002540) | 2.48264619 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 2.46957765 |
| 65 | Tubular atrophy (HP:0000092) | 2.46723205 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.46380390 |
| 67 | Clumsiness (HP:0002312) | 2.46059820 |
| 68 | Petechiae (HP:0000967) | 2.45004643 |
| 69 | White forelock (HP:0002211) | 2.42009859 |
| 70 | Basal ganglia calcification (HP:0002135) | 2.41613085 |
| 71 | Nonprogressive disorder (HP:0003680) | 2.41579990 |
| 72 | Gingivitis (HP:0000230) | 2.40745253 |
| 73 | Joint hemorrhage (HP:0005261) | 2.40330387 |
| 74 | Decreased central vision (HP:0007663) | 2.40105613 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39754972 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39754972 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39754972 |
| 78 | Duplicated collecting system (HP:0000081) | 2.34560158 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.31849639 |
| 80 | Large for gestational age (HP:0001520) | 2.31334235 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.30964299 |
| 82 | Hypothermia (HP:0002045) | 2.28537606 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.27669516 |
| 84 | Thick nail (HP:0001805) | 2.26009492 |
| 85 | Cystic liver disease (HP:0006706) | 2.24902724 |
| 86 | Genetic anticipation (HP:0003743) | 2.23404430 |
| 87 | Abnormality of the renal collecting system (HP:0004742) | 2.22193149 |
| 88 | Medial flaring of the eyebrow (HP:0010747) | 2.17781292 |
| 89 | Cerebellar dysplasia (HP:0007033) | 2.14136784 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13710978 |
| 91 | Congenital, generalized hypertrichosis (HP:0004540) | 2.13291953 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 2.11950414 |
| 93 | Protruding tongue (HP:0010808) | 2.11487292 |
| 94 | Aplasia cutis congenita (HP:0001057) | 2.09787473 |
| 95 | Encephalitis (HP:0002383) | 2.08585160 |
| 96 | Epistaxis (HP:0000421) | 2.07238271 |
| 97 | Chronic diarrhea (HP:0002028) | 2.06898721 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.06108379 |
| 99 | Cheilitis (HP:0100825) | 2.05153451 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 2.04718730 |
| 101 | Concave nail (HP:0001598) | 2.04451907 |
| 102 | Purpura (HP:0000979) | 2.03992816 |
| 103 | Pendular nystagmus (HP:0012043) | 2.03870794 |
| 104 | Anhidrosis (HP:0000970) | 2.03012270 |
| 105 | Furrowed tongue (HP:0000221) | 2.02661233 |
| 106 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.02329326 |
| 107 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.01926437 |
| 108 | Meckel diverticulum (HP:0002245) | 2.01512285 |
| 109 | Vasculitis (HP:0002633) | 1.99391123 |
| 110 | Abnormality of the preputium (HP:0100587) | 1.99182698 |
| 111 | Episodic fever (HP:0001954) | 1.98101254 |
| 112 | Anorexia (HP:0002039) | 1.97364921 |
| 113 | Osteomyelitis (HP:0002754) | 1.97059925 |
| 114 | Panhypogammaglobulinemia (HP:0003139) | 1.96566102 |
| 115 | Hypergonadotropic hypogonadism (HP:0000815) | 1.94722454 |
| 116 | Abnormality of incisor morphology (HP:0011063) | 1.94459099 |
| 117 | Submucous cleft hard palate (HP:0000176) | 1.94328270 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.94317518 |
| 119 | Polyuria (HP:0000103) | 1.94256725 |
| 120 | Lissencephaly (HP:0001339) | 1.93266406 |
| 121 | Agitation (HP:0000713) | 1.92475787 |
| 122 | Parakeratosis (HP:0001036) | 1.91628048 |
| 123 | Abnormality of chromosome stability (HP:0003220) | 1.91432291 |
| 124 | Constricted visual fields (HP:0001133) | 1.91065057 |
| 125 | Increased IgM level (HP:0003496) | 1.90189202 |
| 126 | Abnormality of the pons (HP:0007361) | 1.89803810 |
| 127 | Periodontitis (HP:0000704) | 1.89291516 |
| 128 | Nephritis (HP:0000123) | 1.88940289 |
| 129 | Abnormality of the ileum (HP:0001549) | 1.88754306 |
| 130 | Agnosia (HP:0010524) | 1.87940060 |
| 131 | Severe muscular hypotonia (HP:0006829) | 1.87723355 |
| 132 | Abnormal biliary tract physiology (HP:0012439) | 1.87022826 |
| 133 | Bile duct proliferation (HP:0001408) | 1.87022826 |
| 134 | Keratoconjunctivitis (HP:0001096) | 1.87004248 |
| 135 | Inflammation of the large intestine (HP:0002037) | 1.85924666 |
| 136 | Gaze-evoked nystagmus (HP:0000640) | 1.84630406 |
| 137 | Hypoplasia of the pons (HP:0012110) | 1.84545846 |
| 138 | Congenital hepatic fibrosis (HP:0002612) | 1.84213981 |
| 139 | Abnormality of T cells (HP:0002843) | 1.84036146 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83280302 |
| 141 | Glomerulopathy (HP:0100820) | 1.82267175 |
| 142 | IgG deficiency (HP:0004315) | 1.81649220 |
| 143 | Pulmonary infiltrates (HP:0002113) | 1.81494533 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79356054 |
| 145 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78539901 |
| 146 | Increased corneal curvature (HP:0100692) | 1.78073016 |
| 147 | Keratoconus (HP:0000563) | 1.78073016 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.77540099 |
| 149 | Thyroiditis (HP:0100646) | 1.76016142 |
| 150 | Febrile seizures (HP:0002373) | 1.73822987 |
| 151 | Hemoptysis (HP:0002105) | 1.73276242 |
| 152 | Septo-optic dysplasia (HP:0100842) | 1.73087715 |
| 153 | Chorioretinal atrophy (HP:0000533) | 1.72628726 |
| 154 | Abnormality of T cell physiology (HP:0011840) | 1.72122684 |
| 155 | T lymphocytopenia (HP:0005403) | 1.72025909 |
| 156 | Leukocytosis (HP:0001974) | 1.72000180 |
| 157 | Abnormality of eosinophils (HP:0001879) | 1.70851529 |
| 158 | Hepatosplenomegaly (HP:0001433) | 1.70625377 |
| 159 | Eosinophilia (HP:0001880) | 1.70545175 |
| 160 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70081022 |
| 161 | Absent/shortened dynein arms (HP:0200106) | 1.70081022 |
| 162 | Gingival bleeding (HP:0000225) | 1.69980418 |
| 163 | Pustule (HP:0200039) | 1.69671655 |
| 164 | Conical tooth (HP:0000698) | 1.69488670 |
| 165 | Cellulitis (HP:0100658) | 1.69401463 |
| 166 | Duplication of thumb phalanx (HP:0009942) | 1.68833900 |
| 167 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68809540 |
| 168 | Ectopic kidney (HP:0000086) | 1.68657312 |
| 169 | Fair hair (HP:0002286) | 1.68502376 |
| 170 | Abnormal glycosylation (HP:0012345) | 1.68315136 |
| 171 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.68315136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.10287870 |
| 2 | CASK | 3.45784558 |
| 3 | IRAK3 | 3.37636433 |
| 4 | BLK | 3.35783729 |
| 5 | IRAK4 | 3.32641267 |
| 6 | ACVR1B | 2.95247653 |
| 7 | TXK | 2.80216273 |
| 8 | TGFBR2 | 2.73644441 |
| 9 | MUSK | 2.61699683 |
| 10 | MAP3K14 | 2.57986242 |
| 11 | TLK1 | 2.50040779 |
| 12 | GRK7 | 2.46030562 |
| 13 | CLK1 | 2.26796341 |
| 14 | MKNK2 | 2.16684713 |
| 15 | ZAK | 2.06408056 |
| 16 | DAPK2 | 1.93890979 |
| 17 | TNIK | 1.88410356 |
| 18 | EIF2AK2 | 1.83558600 |
| 19 | TEC | 1.80450008 |
| 20 | WNK4 | 1.78021304 |
| 21 | GRK6 | 1.73188373 |
| 22 | ADRBK2 | 1.72593583 |
| 23 | BMPR1B | 1.67069898 |
| 24 | OXSR1 | 1.59835975 |
| 25 | YES1 | 1.59501078 |
| 26 | IKBKB | 1.53702427 |
| 27 | NEK6 | 1.52779266 |
| 28 | MKNK1 | 1.51738383 |
| 29 | SRPK1 | 1.50560584 |
| 30 | NEK9 | 1.47547030 |
| 31 | NME2 | 1.45073348 |
| 32 | STK16 | 1.43809079 |
| 33 | MAP4K2 | 1.38685354 |
| 34 | WNK3 | 1.38514560 |
| 35 | GRK1 | 1.37958192 |
| 36 | RIPK4 | 1.36811739 |
| 37 | VRK1 | 1.32919032 |
| 38 | BMPR2 | 1.31193798 |
| 39 | ADRBK1 | 1.31115162 |
| 40 | IKBKE | 1.30868965 |
| 41 | MAP4K1 | 1.28499173 |
| 42 | KIT | 1.27861531 |
| 43 | PTK2B | 1.24146074 |
| 44 | PRPF4B | 1.22212625 |
| 45 | BTK | 1.19613687 |
| 46 | LYN | 1.18200052 |
| 47 | MAP3K11 | 1.16968167 |
| 48 | TYK2 | 1.16418853 |
| 49 | TNK2 | 1.15104287 |
| 50 | TIE1 | 1.12707184 |
| 51 | IRAK1 | 1.11121731 |
| 52 | INSRR | 1.09551345 |
| 53 | FES | 1.09147930 |
| 54 | STK11 | 1.08050108 |
| 55 | MST4 | 1.04836791 |
| 56 | IRAK2 | 1.00784096 |
| 57 | MAP2K6 | 1.00325967 |
| 58 | NLK | 0.97631801 |
| 59 | PKN1 | 0.95859670 |
| 60 | MAP2K3 | 0.94026904 |
| 61 | MARK3 | 0.92243947 |
| 62 | SIK2 | 0.91323253 |
| 63 | CSK | 0.89863536 |
| 64 | JAK1 | 0.88542986 |
| 65 | MAP3K12 | 0.87323860 |
| 66 | CDK8 | 0.85111379 |
| 67 | MAPK15 | 0.83723771 |
| 68 | SYK | 0.83409842 |
| 69 | PIM1 | 0.83041544 |
| 70 | CSF1R | 0.81024614 |
| 71 | SGK2 | 0.79977617 |
| 72 | CDK3 | 0.79838733 |
| 73 | HCK | 0.77081635 |
| 74 | MAP2K7 | 0.77063604 |
| 75 | TRPM7 | 0.75274638 |
| 76 | MAPK13 | 0.74649110 |
| 77 | EPHA3 | 0.73840333 |
| 78 | PIM2 | 0.73823278 |
| 79 | KDR | 0.73739647 |
| 80 | TGFBR1 | 0.72402472 |
| 81 | MAP2K4 | 0.71542321 |
| 82 | PAK3 | 0.70441662 |
| 83 | LCK | 0.69950691 |
| 84 | RPS6KA5 | 0.69790944 |
| 85 | NUAK1 | 0.69557945 |
| 86 | PIK3CG | 0.68053004 |
| 87 | MATK | 0.67742743 |
| 88 | MAPK12 | 0.66945802 |
| 89 | TAOK3 | 0.66115152 |
| 90 | CAMKK1 | 0.64655285 |
| 91 | PRKD2 | 0.64433769 |
| 92 | MAP2K2 | 0.64243145 |
| 93 | MAP3K7 | 0.62755261 |
| 94 | PRKAA2 | 0.62688799 |
| 95 | STK39 | 0.61861785 |
| 96 | TBK1 | 0.61518715 |
| 97 | ZAP70 | 0.59989499 |
| 98 | CHUK | 0.59555091 |
| 99 | FGR | 0.58911622 |
| 100 | JAK3 | 0.58328943 |
| 101 | MAPK7 | 0.57484506 |
| 102 | PRKCG | 0.57447954 |
| 103 | PINK1 | 0.55016267 |
| 104 | PRKCH | 0.54981660 |
| 105 | MAPKAPK3 | 0.53638425 |
| 106 | CAMK1 | 0.53494908 |
| 107 | CAMK1D | 0.52742322 |
| 108 | PDK1 | 0.51693867 |
| 109 | PRKCZ | 0.51692312 |
| 110 | TAOK1 | 0.50579680 |
| 111 | CDK19 | 0.50461288 |
| 112 | EPHB1 | 0.49462878 |
| 113 | PDK2 | 0.47840234 |
| 114 | DYRK2 | 0.47553547 |
| 115 | CDK9 | 0.46749936 |
| 116 | PIK3CA | 0.46390263 |
| 117 | WNK1 | 0.44364924 |
| 118 | SIK3 | 0.43520564 |
| 119 | JAK2 | 0.42806729 |
| 120 | PRKCD | 0.42013130 |
| 121 | MAP3K4 | 0.41767683 |
| 122 | CAMK4 | 0.41001093 |
| 123 | ERN1 | 0.40843427 |
| 124 | PTK6 | 0.38617761 |
| 125 | GRK5 | 0.38580382 |
| 126 | RPS6KA6 | 0.38330803 |
| 127 | RPS6KC1 | 0.38068124 |
| 128 | RPS6KL1 | 0.38068124 |
| 129 | MAPKAPK5 | 0.37938556 |
| 130 | MOS | 0.37925714 |
| 131 | MAP2K1 | 0.36634384 |
| 132 | PRKCQ | 0.36607591 |
| 133 | STK4 | 0.36596790 |
| 134 | MAPK4 | 0.36286742 |
| 135 | PRKG2 | 0.34131427 |
| 136 | SGK3 | 0.33040719 |
| 137 | HIPK2 | 0.32307024 |
| 138 | CAMKK2 | 0.31619481 |
| 139 | PRKCE | 0.29042369 |
| 140 | ITK | 0.28524134 |
| 141 | AKT3 | 0.28522961 |
| 142 | STK10 | 0.27005806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.04694111 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72481061 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.32019356 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27310970 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.25288881 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23385107 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22035476 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20124096 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13298510 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08059334 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05261070 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.02547508 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.99988842 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.96943076 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83174704 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.82748638 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.82330921 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.81118639 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.78703912 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70861185 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.69179468 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67360905 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.64525862 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.63233514 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59697383 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59103943 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57517939 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53327808 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49581784 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48380945 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46615326 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.42742260 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.42228386 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.38610832 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37418531 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.31418595 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30004868 |
| 38 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.29199562 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28478366 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26232190 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24098528 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23216398 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21329314 |
| 44 | Nicotine addiction_Homo sapiens_hsa05033 | 1.19375998 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.18029389 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16622945 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16607993 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13757004 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13634037 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11654572 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.08462854 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.06072526 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 1.05969232 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02957728 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02393882 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01785515 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01203478 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00927702 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.97339250 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.96657991 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93813091 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93675604 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.93398968 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92418505 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89051091 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.88425433 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86859785 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86198802 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85124773 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84574763 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83867966 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83840392 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81505803 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81059939 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79431755 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.77554531 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76575077 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.76388703 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.75389179 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73120678 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72863224 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72234434 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72142813 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71731377 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62397892 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62146934 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61401038 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60727410 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.59403435 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58804431 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58511831 |
| 92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58329790 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58169845 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.57552246 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57144623 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.56767846 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56692101 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.55864102 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55730033 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.55229000 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54041284 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.53877695 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.53656545 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52984704 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.52785999 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51202717 |
| 107 | Long-term depression_Homo sapiens_hsa04730 | 0.50447353 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50312646 |
| 109 | Taste transduction_Homo sapiens_hsa04742 | 0.50174403 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49468062 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49371236 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.49285036 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48762448 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48505135 |
| 115 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47262816 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.46300338 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45795436 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44654030 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.42696982 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42543094 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40457354 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40411248 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.38474140 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37953601 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36867226 |
| 126 | DNA replication_Homo sapiens_hsa03030 | 0.36796244 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.36546264 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35499991 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34392357 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33991510 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32198233 |
| 132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31700731 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30558653 |
| 134 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29809588 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29347630 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.28348913 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27207558 |
| 138 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26304987 |

